PeptideDB

Erlotinib-d6

CAS No.: 1034651-23-4

Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib .
Synonyms OSI-774 D6, NSC 718781 D6, CP-358774 D6
molecular weight 399.47
Molecular formula C22H23N3O4
CAS 1034651-23-4
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997, 57(21), 4838-4848.